期刊文献+

灯盏花素调节PI3K/AKT通路增强人非小细胞肺癌A549细胞顺铂化疗敏感性 被引量:2

Calendulin Enhancing Cisplatin Chemosensitivity in Human Non-small Cell Lung Cancer A549 Cells by Regulating PI3K/AKT pathway
暂未订购
导出
摘要 目的:观察灯盏花素对人非小细胞肺癌A549细胞顺铂化疗敏感性的影响,并基于磷脂酰肌醇3-激酶/蛋白激酶B(phosphatidylinositol-3-kinase/protein kinase B,PI3K/AKT)通路探讨潜在作用机制。方法:以0、2、4、8、16、32μmol·L^(-1)灯盏花素和0、1、2、4、8、16μmol·L^(-1)顺铂干预A549细胞,MTT法检测细胞增殖活力,并计算半抑制浓度IC_(50灯盏花素)和IC_(50顺铂)。将A549细胞分为空白组、灯盏花素组、顺铂组、灯盏花素+顺铂组、灯盏花素+顺铂+LY294002组。培养48 h后,MTT法检测细胞活力,平板克隆实验检测细胞克隆形成能力,流式细胞术检测细胞凋亡,RT-PCR法检测细胞PI3K、AKT基因表达水平,Western blot法检测细胞PI3K、AKT、B细胞淋巴瘤-2(B-cell lymphoma-2,Bcl-2)、Bcl-2相关X蛋白(Bax)、半胱氨酸蛋白酶(Caspase)-9、Cleaved Caspase-9、Caspase-3、Cleaved Caspase-3蛋白表达水平。结果:灯盏花素和顺铂对A549细胞增殖活力的抑制作用均呈剂量依赖性,IC 50灯盏花素和IC_(50顺铂)分别为14.36μmol·L^(-1)和5.72μmol·L^(-1)。与空白组相比,其余组细胞增殖活力、克隆形成数目降低,凋亡率升高,PI3K mRNA、AKT mRNA水平降低(P<0.05)。与灯盏花素组或顺铂组相比,灯盏花素+顺铂组和灯盏花素+顺铂+LY294002组细胞增殖活力、克隆形成数目降低,凋亡率升高,PI3K mRNA、AKT mRNA水平降低(P<0.05)。与灯盏花素+顺铂组相比,灯盏花素+顺铂+LY294002组细胞增殖活力、克隆形成数目降低,凋亡率升高,PI3K mRNA、AKT mRNA水平降低(P<0.05)。与空白组相比,其余组细胞PI3K、AKT、Bcl-2蛋白表达水平降低,Bax、Cleaved Caspase-9、Cleaved Caspase-3蛋白表达水平及Bax/Bcl-2、Cleaved Caspase-9/Caspase-9、Cleaved Caspase-3/Caspase-3比值升高(P<0.05)。与灯盏花素组或顺铂组相比,灯盏花素+顺铂组和灯盏花素+顺铂+LY294002组细胞PI3K、AKT、Bcl-2蛋白表达水平降低,Bax、Cleaved Caspase-9、Cleaved Caspase-3蛋白表达水平及Bax/Bcl-2、Cleaved Caspase-9/Caspase-9、Cleaved Caspase-3/Caspase-3比值升高(P<0.05)。与灯盏花素+顺铂组相比,灯盏花素+顺铂+LY294002组细胞PI3K、AKT、Bcl-2蛋白表达水平降低,Bax、Cleaved Caspase-9、Cleaved Caspase-3蛋白表达水平及Bax/Bcl-2、Cleaved Caspase-9/Caspase-9、Cleaved Caspase-3/Caspase-3比值升高(P<0.05)。结论:灯盏花素可能通过抑制PI3K/AKT通路,抑制细胞增殖并促进其凋亡,从而增强A549细胞化疗敏感性。 Objective:To observe the effect of lanugoin on the sensitivity of human non-small cell lung cancer A549 cells to cisplatin chemotherapy,and to explore the potential mechanism of action based on phosphatidylinositol-3-kinase/protein kinase B(PI3K/AKT)pathway.Methods:A549 cells were intervened with 0,2,4,8,16,and 32μmol·L^(-1) luciferin and 0,1,2,4,8,and 16μmol·L^(-1) cisplatin,and the cell proliferation viability was detected by MTT assay,and the semi-inhibitory concentrations IC_(50 luciferin) and IC_(50 cisplatin) were calculated.The A549 cells were divided into blank group,lamparicin group,cisplatin group,lamparicin+cisplatin group,and lamparicin+cisplatin+LY294002 group.After 48 h of culture,cell viability was detected by MTT assay,cell clone formation ability was detected by plate cloning assay,cell apoptosis was detected by flow cytometry,cell expression levels of PI3K and AKT genes were detected by RT-PCR,and cell PI3K,AKT,B-cell lymphoma-2(Bcl-2),Bcl-2-related X protein(Bax),cysteine protease(Caspase)-9,Cleaved Caspase-9,Caspase-3,Cleaved Caspase-3 protein expression levels.Results:The inhibitory effects of both lamprophyllin and cisplatin on the proliferation viability of A549 cells were dose-dependent,with IC50 lamprophyllin and IC 50 cisplatin being 14.36μmol·L^(-1) and 5.72μmol·L^(-1),respectively.compared with the blank group,the proliferation viability and the number of clone formation of the cells in the rest of the group were reduced,the apoptosis rate was elevated,and the levels of PI3K mRNA and AKT mRNA were decreased(P<0.05).Compared with the lanugin group or the cisplatin group,the cell proliferation vigor,the number of clone formation decreased,the apoptosis rate increased,and the levels of PI3K mRNA and AKT mRNA decreased in the lanugin+cisplatin group and the lanugin+cisplatin+LY294002 group(P<0.05).Compared with the lanugin+cisplatin group,cell proliferation vigor,number of clone formation decreased,apoptosis rate increased,and PI3K mRNA,AKT mRNA levels decreased in the lanugin+cisplatin+LY294002 group(P<0.05).Compared with the blank group,the cellular PI3K,AKT,and Bcl-2 protein expression levels were reduced in the rest of the group,and the protein expression levels of Bax,Cleaved Caspase-9,Cleaved Caspase-3 and Bax/Bcl-2,Cleaved Caspase-9/Caspase-9,Cleaved Caspase-3/Caspase-3 ratio were elevated(P<0.05).Compared with the lanugin group or the cisplatin group,the cellular PI3K,AKT,and Bcl-2 protein expression levels were decreased in the lanugin+cisplatin group and the lanugin+cisplatin+LY294002 group,and the protein expression levels of Bax,Cleaved Caspase-9,and Cleaved Caspase-3 protein expression levels and the ratio of Bax/Bcl-2,Cleaved Caspase-9/Caspase-9,and Cleaved Caspase-3/Caspase-3 ratio were elevated(P<0.05).Compared with the lanugin+cisplatin group,the cellular PI3K,AKT,and Bcl-2 protein expression levels were decreased in the lanugin+cisplatin+LY294002 group,and the protein expression levels of Bax,Cleaved Caspase-9,Cleaved Caspase-3,and the ratios of Bax/Bcl-2,Cleaved Caspase-9/Caspase-3/Caspase-3 were increased(P<0.05).Conclusion:Lampetin may enhance the chemosensitivity of A549 cells by inhibiting cell proliferation and promoting apoptosis through inhibiting the PI3K/AKT pathway.
作者 韦辉 王天珩 高世奇 WEI Hui;WANG Tianheng;GAO Shiqi(The First Hospital of Handan,Handan Hebei China 056002)
机构地区 邯郸市第一医院
出处 《中医学报》 2025年第5期1108-1115,共8页 Acta Chinese Medicine
基金 河北省医学科学研究课题项目(20220506)。
关键词 非小细胞肺癌 灯盏花素 顺铂 A549细胞 PI3K/AKT通路 化疗 non-small cell lung cancer calendulin cisplatin A549 cell PI3K/AKT pathway chemotherapy
  • 相关文献

参考文献12

二级参考文献53

  • 1Roger Stupp,Monika E Hegi,Warren P Mason,Martin J van den Bent,Martin JB Taphoorn,Robert C Janzer,Samuel K Ludwin,Anouk Allgeier,Barbara Fisher,Karl Belanger,Peter Hau,Alba A Brandes,Johanna Gijtenbeek,Christine Marosi,Charles J Vecht,Karima Mokhtari,Pieter Wesseling,Salvador Villa,Elizabeth Eisenhauer,Thierry Gorlia,Michael Weller,Denis Lacombe,J Gregory Cairncross,René-Olivier Mirimanoff.Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial[J]. Lancet Oncology . 2009 (5)
  • 2Cahill Daniel P,Levine Kymberly K,Betensky Rebecca A,Codd Patrick J,Romany Candice A,Reavie Linsey B,Batchelor Tracy T,Futreal P Andrew,Stratton Michael R,Curry William T,Iafrate A John,Louis David N.Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment. Clinical cancer research : an official journal of the American Association for Cancer Research . 2007
  • 3Yabroff K Robin,Harlan Linda,Zeruto Christopher,Abrams Jeffrey,Mann Bhupinder.Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006. Neuro oncology . 2012
  • 4David Sadava,Susan E. Kane.??Silibinin reverses drug resistance in human small-cell lung carcinoma cells(J)Cancer Letters . 2013
  • 5Mohammad Reza Noori-Daloii,Mojtaba Saffari,Reza Raoofian,MirSaeed Yekaninejad,Orkideh Saydi Dinehkabodi,Ali Reza Noori-Daloii.??The multidrug resistance pumps are inhibited by silibinin and apoptosis induced in K562 and KCL22 leukemia cell lines(J)Leukemia Research . 2013
  • 6Xinxin Yang,Xiaoyu Li,Liangxiang An,Bo Bai,Jing Chen.??Silibinin induced the apoptosis of Hep-2 cells via oxidative stress and down-regulating survivin expression(J)European Archives of Oto-Rhino-Laryngology . 2013 (8)
  • 7Son Yong-Gyu,Kim Eun Hee,Kim Jin Yeop,Kim Seung U,Kwon Taeg Kyu,Yoon A-Rum,Yun Chae-Ok,Choi Kyeong Sook.Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin. Cancer Research . 2007
  • 8Xia Xie,Bo Tang,Jianyun Zhou,Qing Gao,Pengbing Zhang.??Inhibition of the PI3K/Akt pathway increases the chemosensitivity ofgastric cancer to vincristine(J)Oncology Reports . 2013 (2)
  • 9Ge Y,Zhang Y,Chen Y, et al.Silibinin Causes Apoptosis and Cell CycleArrest in Some Human Pancreatic Cancer Cells. Int J Mol Sci . 2011
  • 10Sathornsumetee Sith,Rich Jeremy N.New treatment strategies for malignant gliomas. Expert review of anticancer therapy . 2006

共引文献194

同被引文献21

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部